Cheezheng Tibetan Medicine secures 3.6 bn yuan credit line, expands guarantees

Tibet Cheezheng Tibetan Medicine (SZSE:002287) announced on December 23, 2025, it will provide a guarantee limit of up to 700 million yuan for its wholly-owned subsidiary, Tibet Cheezheng Tibetan Medicine Marketing Co., Ltd., for comprehensive credit facilities. This guarantee, effective for 12 months from shareholder approval, follows the subsidiary's latest asset-liability ratio of below 70%.

Concurrently, Cheezheng Tibetan Medicine and its subsidiaries plan to apply for a comprehensive credit line of up to 3.6 billion yuan from banks, valid for 36 months. Additionally, the company will engage in bill pool business with various domestic commercial banks, with a total limit not exceeding 650 million yuan. This includes providing a guarantee of 200 million yuan for its three subsidiaries—Gansu Cheezheng Tibetan Medicine, Gansu Fogetang Tibetan Medicine, and Tibet Tibetan Medicine Group—for bill pool pledge financing.

These proposals, approved by the Sixth Board of Directors at its sixteenth meeting on December 22, 2025, are subject to shareholder approval. The initiatives aim to optimize the capital structure, enhance liquidity, and support the business development of the company and its subsidiaries.